11,795 Shares in DENTSPLY SIRONA Inc. $XRAY Bought by Park Avenue Securities LLC

Park Avenue Securities LLC acquired a new stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 11,795 shares of the medical instruments supplier’s stock, valued at approximately $187,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Gabelli Funds LLC lifted its holdings in shares of DENTSPLY SIRONA by 1.0% during the first quarter. Gabelli Funds LLC now owns 98,000 shares of the medical instruments supplier’s stock valued at $1,464,000 after acquiring an additional 1,000 shares during the period. Empowered Funds LLC lifted its holdings in shares of DENTSPLY SIRONA by 8.8% during the first quarter. Empowered Funds LLC now owns 16,324 shares of the medical instruments supplier’s stock valued at $244,000 after acquiring an additional 1,320 shares during the period. Covestor Ltd lifted its holdings in shares of DENTSPLY SIRONA by 17.5% during the first quarter. Covestor Ltd now owns 9,778 shares of the medical instruments supplier’s stock valued at $146,000 after acquiring an additional 1,456 shares during the period. Mirae Asset Global Investments Co. Ltd. bought a new position in shares of DENTSPLY SIRONA during the first quarter valued at $25,000. Finally, Principal Financial Group Inc. lifted its holdings in shares of DENTSPLY SIRONA by 0.4% during the first quarter. Principal Financial Group Inc. now owns 457,397 shares of the medical instruments supplier’s stock valued at $6,834,000 after acquiring an additional 1,708 shares during the period. 95.70% of the stock is owned by institutional investors.

DENTSPLY SIRONA Stock Up 0.1%

XRAY opened at $12.96 on Friday. DENTSPLY SIRONA Inc. has a 1-year low of $12.14 and a 1-year high of $25.23. The stock’s fifty day simple moving average is $13.85 and its 200 day simple moving average is $14.74. The company has a current ratio of 1.69, a quick ratio of 1.11 and a debt-to-equity ratio of 1.13. The stock has a market cap of $2.59 billion, a PE ratio of -2.73, a price-to-earnings-growth ratio of 0.81 and a beta of 0.96.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $0.52 EPS for the quarter, beating analysts’ consensus estimates of $0.50 by $0.02. The firm had revenue of $936.00 million for the quarter, compared to analyst estimates of $929.67 million. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The company’s revenue for the quarter was down 4.9% on a year-over-year basis. During the same period in the prior year, the firm posted $0.49 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. As a group, research analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 10th. Shareholders of record on Friday, September 26th will be given a $0.16 dividend. The ex-dividend date is Friday, September 26th. This represents a $0.64 annualized dividend and a yield of 4.9%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -13.50%.

Analyst Ratings Changes

XRAY has been the subject of a number of research reports. Wells Fargo & Company lowered their target price on DENTSPLY SIRONA from $16.00 to $15.00 and set an “equal weight” rating for the company in a research note on Friday, August 8th. Stifel Nicolaus lowered their price objective on DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating for the company in a research report on Friday, August 8th. Wall Street Zen upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Friday, September 26th. Barrington Research decreased their target price on DENTSPLY SIRONA from $21.00 to $18.00 and set an “outperform” rating for the company in a research report on Friday, August 8th. Finally, UBS Group decreased their price objective on DENTSPLY SIRONA from $25.00 to $24.00 and set a “buy” rating for the company in a research report on Friday, August 8th. Two analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $18.64.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.